Vita Life Sciences
(ASX) VLS
Vita Life Sciences Financials at a Glance
Market Cap
A$135.57M
Revenue (TTM)
A$172.78M
Net Income (TTM)
A$19.22M
EPS (TTM)
A$0.18
P/E Ratio
13.69
Dividend
A$0.14
Beta (Volatility)
-0.04 (Low)
Dividend
A$0.14
Beta (Volatility)
-0.04 (Low)
Price
A$2.55
Volume
9,598
Open
A$2.50
Price
A$2.55
Volume
9,598
Open
A$2.50
Previous Close
A$2.55
Daily Range
A$2.50 - A$2.55
52-Week Range
A$2.06 - A$2.84
Estimated Earnings Date
Feb 22, 2026
Dividend
A$0.14
Beta (Volatility)
-0.04 (Low)
Price
A$2.55
Volume
9,598
Open
A$2.50
Previous Close
A$2.55
Daily Range
A$2.50 - A$2.55
52-Week Range
A$2.06 - A$2.84
Estimated Earnings Date
Feb 22, 2026
VLS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vita Life Sciences
Industry
Pharmaceuticals
Sector
Health CareCEO
Andrew OKeefe
Website
www.vitalifesciences.comHeadquarters
Kirrawee, NSW 2232, AU
VLS Financials
Key Financial Metrics (TTM)
Gross Margin
61%
Operating Margin
16%
Net Income Margin
11%
Return on Equity
19%
Return on Capital
25%
Return on Assets
13%
Earnings Yield
7.30%
Dividend Yield
5.49%
Payout Ratio
58.26%
Stock Overview
Market Cap
A$135.57M
Shares Outstanding
53.17M
Volume
9.60K
Avg. Volume
15.08K
Financials (TTM)
Gross Profit
A$56.03M
Operating Income
A$14.66M
EBITDA
A$15.67M
Operating Cash Flow
A$16.43M
Capital Expenditure
-A$570.00K
Free Cash Flow
A$15.86M
Cash & ST Invst.
A$35.56M
Total Debt
A$4.30M
Vita Life Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
A$47.73M
+20.9%
Gross Profit
A$29.65M
+29.3%
Gross Margin
62.12%
N/A
Market Cap
A$135.57M
N/A
Market Cap/Employee
A$338.94K
N/A
Employees
400
N/A
Net Income
A$5.60M
+9.8%
EBITDA
A$7.71M
+5.2%
Quarterly Fundamentals
Total Cash
A$35.56M
+44.4%
Total Debt
A$4.30M
+1012.1%
Accounts Receivable
A$13.64M
+21.6%
Inventory
A$15.08M
+35.2%
Long Term Debt
A$3.82M
+2071.6%
Short Term Debt
A$482.00K
+14.2%
Return on Assets
12.67%
N/A
Return on Invested Capital
25.19%
N/A
Free Cash Flow
A$9.99M
+27.4%
Operating Cash Flow
A$9.83M
+16.8%